E Fund Management Co., Ltd. Adma Biologics, Inc. Transaction History
E Fund Management Co., Ltd.
- $2.07 Billion
- Q1 2025
A detailed history of E Fund Management Co., Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 20,872 shares of ADMA stock, worth $388,010. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,872
Previous 36,469
42.77%
Holding current value
$388,010
Previous $625,000
33.76%
% of portfolio
0.02%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding ADMA
# of Institutions
391Shares Held
190MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$347 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$313 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$239 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$213 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$105 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.65B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...